These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 2572028

  • 1. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V, Rossignol P, Roques BP.
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes.
    Daugé V, Rossignol P, Roques BP.
    Psychopharmacology (Berl); 1988; 96(3):343-52. PubMed ID: 2851851
    [Abstract] [Full Text] [Related]

  • 3. Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release.
    Petit F, Hamon M, Fournie-Zaluski MC, Roques BP, Glowinski J.
    Eur J Pharmacol; 1986 Jul 15; 126(1-2):1-9. PubMed ID: 3019709
    [Abstract] [Full Text] [Related]

  • 4. Lesion of dopamine mesolimbic neurons blocks behavioral effects induced by the endogenous enkephalins but not by a mu-opioid receptor agonist.
    Calenco-Choukroun G, Daugé V, Gacel G, Roques BP.
    Eur J Pharmacol; 1991 Dec 17; 209(3):267-71. PubMed ID: 1665799
    [Abstract] [Full Text] [Related]

  • 5. Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration.
    de Witte P, Heidbreder C, Roques BP.
    Neuropharmacology; 1989 Jul 17; 28(7):667-76. PubMed ID: 2761678
    [Abstract] [Full Text] [Related]

  • 6. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
    Churchill L, Kalivas PW.
    Synapse; 1992 May 17; 11(1):47-57. PubMed ID: 1318584
    [Abstract] [Full Text] [Related]

  • 7. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ, Mulder AH, Schoffelmeer AN.
    J Neurochem; 1990 Oct 17; 55(4):1274-80. PubMed ID: 2168934
    [Abstract] [Full Text] [Related]

  • 8. Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area.
    Calenco-Choukroun G, Daugé V, Gacel G, Féger J, Roques BP.
    Psychopharmacology (Berl); 1991 Oct 17; 103(4):493-502. PubMed ID: 1648248
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S, Búzás B, Cox BM.
    J Pharmacol Exp Ther; 1993 Oct 17; 267(1):145-52. PubMed ID: 7901389
    [Abstract] [Full Text] [Related]

  • 10. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
    Meucci E, Delay-Goyet P, Roques BP, Zajac JM.
    Eur J Pharmacol; 1989 Nov 21; 171(2-3):167-78. PubMed ID: 2559856
    [Abstract] [Full Text] [Related]

  • 11. Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats.
    Maldonado R, Daugé V, Feger J, Roques BP.
    Neuropharmacology; 1990 Mar 21; 29(3):215-23. PubMed ID: 2157999
    [Abstract] [Full Text] [Related]

  • 12. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH, Padt M, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN.
    Eur J Pharmacol; 1990 Jun 08; 181(3):267-78. PubMed ID: 2166675
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of enkephalin metabolism and activation of mu- or delta-opioid receptors elicit opposite effects on reward and motility in the ventral mesencephalon.
    Heidbreder C, Gewiss M, Lallemand S, Roques BP, De Witte P.
    Neuropharmacology; 1992 Mar 08; 31(3):293-8. PubMed ID: 1321359
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
    Arenas E, Alberch J, Marsal J.
    Neuroscience; 1991 Mar 08; 42(3):707-14. PubMed ID: 1683474
    [Abstract] [Full Text] [Related]

  • 15. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F, Cox BM.
    Br J Pharmacol; 1996 Jan 08; 117(1):161-9. PubMed ID: 8825358
    [Abstract] [Full Text] [Related]

  • 16. The mu rather than the delta subtype of opioid receptors appears to be involved in enkephalin-induced analgesia.
    Chaillet P, Coulaud A, Zajac JM, Fournie-Zaluski MC, Costentin J, Roques BP.
    Eur J Pharmacol; 1984 May 18; 101(1-2):83-90. PubMed ID: 6086366
    [Abstract] [Full Text] [Related]

  • 17. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats.
    Noel MB, Gratton A.
    Synapse; 1995 Oct 18; 21(2):110-22. PubMed ID: 8584972
    [Abstract] [Full Text] [Related]

  • 18. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens.
    Longoni R, Spina L, Mulas A, Carboni E, Garau L, Melchiorri P, Di Chiara G.
    J Neurosci; 1991 Jun 18; 11(6):1565-76. PubMed ID: 1646295
    [Abstract] [Full Text] [Related]

  • 19. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A, Petrillo P, La Regina A, Sbacchi M.
    J Pharmacol Exp Ther; 1990 Jul 18; 254(1):91-7. PubMed ID: 2164103
    [Abstract] [Full Text] [Related]

  • 20. Use of mu and delta opioid peptides of various selectivity gives further evidence of specific involvement of mu opioid receptors in supraspinal analgesia (tail-flick test).
    Dauge V, Petit F, Rossignol P, Roques BP.
    Eur J Pharmacol; 1987 Sep 11; 141(2):171-8. PubMed ID: 2824213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.